Chemo-radiotherapy in non-small cell lung cancer: The role of gemcitabine

Francesco Cellini, Alfredo Cesario, Pierluigi Granone, L. Trodella, R. M. D'Angelillo, S. Ramella, F. Cellini, M. Ciresa

Risultato della ricerca: Contributo in rivistaArticolo in rivista

Abstract

Gemcitabine (2′-2′-difluorodeoxycytidine) is a well-known cytotoxic drug and a potent radio-enhancer. We herein report the in vitro evidence of its activity, and the clinical experiences when this drug is administered concurrently with radiation. The phase I-II trials are analyzed, focusing on the recent ability to deliver irradiation with low incidence of side effects. © 2006 Oxford University Press.
Lingua originaleEnglish
pagine (da-a)v52-v54
RivistaAnnals of Oncology
Volume17
DOI
Stato di pubblicazionePubblicato - 2006

Keywords

  • n/a

Fingerprint

Entra nei temi di ricerca di 'Chemo-radiotherapy in non-small cell lung cancer: The role of gemcitabine'. Insieme formano una fingerprint unica.

Cita questo